Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinsuke Yasuda

Showing results (31-40 of 153) with videos related to

Pageof 16
Sort By:
Internal Medicine (Tokyo, Japan)|February 17, 2017
Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and CyclophosphamideEri Sugawara, Masaru Kato, Ryo Hisada, et al.
Arthritis and Rheumatism|September 6, 2005
Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich elementJun Fukae, Yoshiharu Amasaki, Yumi Yamashita, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 7, 2015
[Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome]Yuichiro Fujieda, Haruki Shida, Kenji Oku, et al.
Arthritis Research & Therapy|April 29, 2022
Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's diseaseFumiaki Kondo, Takahiko Sugihara, Natsuka Umezawa, et al.
IBRO Neuroscience Reports|July 21, 2025
Long COVID is associated with female sex; Anti-NCAM1 autoantibodies are absent in patients with long COVIDYukiko Motokawa, Jun Sugihara, Tomoya Tateishi, et al.
Arthritis Research & Therapy|April 16, 2024
Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational studyZento Yamada, Sei Muraoka, Mai Kawazoe, et al.
Clinics (Sao Paulo, Brazil)|January 29, 2025
Prolonged high Myl9 levels are associated with the pathogenesis and respiratory symptom of post-acute COVID-19 syndrome: A 6-month follow-up studyJun Sugihara, Chiaki Iwamura, Tomoya Tateishi, et al.
Arthritis Care & Research|July 8, 2017
First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β<sub>2</sub> -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies TestsHiroyuki Nakamura, Kenji Oku, Olga Amengual, et al.
Journal of Fungi (Basel, Switzerland)|June 25, 2025
Proposed Diagnostic Criteria for Invasive Pulmonary Aspergillosis in Patients with Autoimmune Inflammatory Rheumatic Diseases: A Proof-of-Concept StudyTakashi Kurita, Koh Okamoto, Noritaka Sekiya, et al.
Modern Rheumatology|February 22, 2019
Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot studyAtsushi Noguchi, Shinsuke Yasuda, Ryo Hisada, et al.
Pageof 16

Showing results (31-40 of 153) with videos related to

Sort By:
Pageof 16
Internal Medicine (Tokyo, Japan)|February 17, 2017
Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and CyclophosphamideEri Sugawara, Masaru Kato, Ryo Hisada, et al.
Arthritis and Rheumatism|September 6, 2005
Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich elementJun Fukae, Yoshiharu Amasaki, Yumi Yamashita, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 7, 2015
[Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome]Yuichiro Fujieda, Haruki Shida, Kenji Oku, et al.
Arthritis Research & Therapy|April 29, 2022
Associated factors with poor treatment response to initial glucocorticoid therapy in patients with adult-onset Still's diseaseFumiaki Kondo, Takahiko Sugihara, Natsuka Umezawa, et al.
IBRO Neuroscience Reports|July 21, 2025
Long COVID is associated with female sex; Anti-NCAM1 autoantibodies are absent in patients with long COVIDYukiko Motokawa, Jun Sugihara, Tomoya Tateishi, et al.
Arthritis Research & Therapy|April 16, 2024
Long-term effects of abatacept on atherosclerosis and arthritis in older vs. younger patients with rheumatoid arthritis: 3-year results of a prospective, multicenter, observational studyZento Yamada, Sei Muraoka, Mai Kawazoe, et al.
Clinics (Sao Paulo, Brazil)|January 29, 2025
Prolonged high Myl9 levels are associated with the pathogenesis and respiratory symptom of post-acute COVID-19 syndrome: A 6-month follow-up studyJun Sugihara, Chiaki Iwamura, Tomoya Tateishi, et al.
Arthritis Care & Research|July 8, 2017
First-Line, Non-Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti-β<sub>2</sub> -Glycoprotein I Domain I and Anti-Phosphatidylserine/Prothrombin Complex Antibodies TestsHiroyuki Nakamura, Kenji Oku, Olga Amengual, et al.
Journal of Fungi (Basel, Switzerland)|June 25, 2025
Proposed Diagnostic Criteria for Invasive Pulmonary Aspergillosis in Patients with Autoimmune Inflammatory Rheumatic Diseases: A Proof-of-Concept StudyTakashi Kurita, Koh Okamoto, Noritaka Sekiya, et al.
Modern Rheumatology|February 22, 2019
Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot studyAtsushi Noguchi, Shinsuke Yasuda, Ryo Hisada, et al.
Pageof 16